These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 338308
1. Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension. Planz G, Gierlichs HW, Hawlina A, Planz R, Stephany W, Rahn KH. Eur J Clin Pharmacol; 1977 Dec 02; 12(4):241-5. PubMed ID: 338308 [No Abstract] [Full Text] [Related]
3. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat]. Cohen Y, Wepierre J, Jacquot C, Rapin J. Arch Int Pharmacodyn Ther; 1974 Feb 02; 207(2):348-60. PubMed ID: 4827419 [No Abstract] [Full Text] [Related]
6. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)]. Brahm M. Ugeskr Laeger; 1973 May 17; 135(20):974-6. PubMed ID: 4585571 [No Abstract] [Full Text] [Related]
7. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial. Muiesan G, Agabiti-Rosei E, Alicandri C, Motolese M. Clin Exp Pharmacol Physiol Suppl; 1978 May 17; 4():35-41. PubMed ID: 354827 [Abstract] [Full Text] [Related]
12. Evidence for a predominantly central hypotensive effect of alpha-methyldopa in humans. Bobik A, Jennings G, Jackman G, Oddie C, Korner P. Hypertension; 1986 Jan 04; 8(1):16-23. PubMed ID: 3943883 [Abstract] [Full Text] [Related]
13. [Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)]. Geissbühler F, Widmer J. J Clin Chem Clin Biochem; 1976 Nov 04; 14(11):543-7. PubMed ID: 1003116 [Abstract] [Full Text] [Related]
15. The antihypertensive effect of guanfacine compared with methyldopa. van der Merwe CJ, Kruger SA. S Afr Med J; 1980 Mar 15; 57(11):400-4. PubMed ID: 6105713 [Abstract] [Full Text] [Related]
16. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo. Mroczek WJ, Fotiu S, Davidov ME, Finnerty FA. Curr Ther Res Clin Exp; 1974 Aug 15; 16(8):769-77. PubMed ID: 4217243 [No Abstract] [Full Text] [Related]
18. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents. Brunner HR, Waeber B, Ferguson RK, Turini GA, Gavras H. Cardiology; 1979 Aug 15; 64 Suppl 1():88-95. PubMed ID: 42489 [No Abstract] [Full Text] [Related]
19. Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension. Routledge PA, Zrinzo LV, Rao JG, Walden RJ, Davies DM, Rawlins MD. Eur J Clin Pharmacol; 1977 Mar 11; 11(3):159-62. PubMed ID: 323023 [Abstract] [Full Text] [Related]